Literature DB >> 1933592

Use of a marker of collagen formation in osteoporosis studies.

J Risteli1, J Melkko, S Niemi, L Risteli.   

Abstract

Type I collagen accounts for most of the organic matrix of bones, but it is also an important constituent of soft connective tissue. Assessment of the turnover of such collagen is particularly relevant to bone metabolism. Determination of the carboxyterminal propeptide of type I procollagen (PICP) is a means of estimating the rate of type I collagen synthesis in the body. Serum concentrations of PICP have been shown to correlate with the rate of bone formation.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1933592     DOI： 10.1007/bf02555083

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN： 0171-967X            Impact factor:   4.333


  7 in total

1.  Radioimmunoassay for human procollagen.

Authors:  M B Taubman; B Goldberg; C Sherr
Journal:  Science       Date:  1974-12-20       Impact factor: 47.728

2.  Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells.

Authors:  B Smedsrød; J Melkko; L Risteli; J Risteli
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

3.  External thoracic duct-venous shunt in conscious pigs for long term studies of connective tissue metabolites in lymph.

Authors:  L T Jensen; H P Olesen; J Risteli; I Lorenzen
Journal:  Lab Anim Sci       Date:  1990-11

4.  Synthesis of type I collagen in healing wounds in humans.

Authors:  K Haukipuro; J Melkko; L Risteli; M Kairaluoma; J Risteli
Journal:  Ann Surg       Date:  1991-01       Impact factor: 12.969

5.  The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones.

Authors:  C Hassager; L T Jensen; J S Johansen; B J Riis; J Melkko; J Pødenphant; L Risteli; C Christiansen; J Risteli
Journal:  Metabolism       Date:  1991-02       Impact factor: 8.694

6.  Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase.

Authors:  A M Parfitt; L S Simon; A R Villanueva; S M Krane
Journal:  J Bone Miner Res       Date:  1987-10       Impact factor: 6.741

7.  Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen.

Authors:  J Melkko; S Niemi; L Risteli; J Risteli
Journal:  Clin Chem       Date:  1990-07       Impact factor: 8.327
  7 in total
  6 in total

1.  The effects of brisk walking on markers of bone and calcium metabolism in postmenopausal women.

Authors:  K Thorsen; A Kristoffersson; R Lorentzon
Journal:  Calcif Tissue Int       Date:  1996-04       Impact factor: 4.333

2.  Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis.

Authors:  W F Lems; W G Jacobs; J W Bijlsma; A Croone; H C Haanen; H H Houben; M I Gerrits; H J van Rijn
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  Acute effects of nasal salmon calcitonin on calcium and bone metabolism.

Authors:  G Thamsborg; S G Skousgaard; H Daugaard; S Schifter; G Kollerup; O H Sørensen
Journal:  Calcif Tissue Int       Date:  1993-10       Impact factor: 4.333

4.  The influence of partial gastrectomy on biochemical parameters of bone metabolism and bone density.

Authors:  H Resch; P Pietschmann; B Pernecker; E Krexner; R Willvonseder
Journal:  Clin Investig       Date:  1992-05

5.  Bone turnover is reduced in children with juvenile rheumatoid arthritis.

Authors:  F Falcini; M Ermini; F Bagnoli
Journal:  J Endocrinol Invest       Date:  1998-01       Impact factor: 4.256

6.  Quantitative analysis of serum procollagen type I C-terminal propeptide by immunoassay on microchip.

Authors:  Shouki Yatsushiro; Rie Akamine; Shohei Yamamura; Mami Hino; Kazuaki Kajimoto; Kaori Abe; Hiroko Abe; Jun-ichi Kido; Masato Tanaka; Yasuo Shinohara; Yoshinobu Baba; Toshihiko Ooie; Masatoshi Kataoka
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.